Rituximab in treatment of phospholipase A2 receptor associated membranous nephropathy combined with mesangial hyperplasia and crescentic formation: a case report
Author:
Affiliation:
Clc Number:
R692.6
Fund Project:
Supported by National Natural Science Foundation of China (81300613).
Related Videos
Share
Article Metrics
- Abstract:
- PDF:
- HTML:
- Cited by:
History
- Received:January 29,2022
- Revised:June 28,2022
- Adopted:
- Online: January 12,2023
- Published: November 20,2022
Article QR Code
